Location History:
- Tel Aviv, IL (2017 - 2019)
- Kfar Saba, IL (2019)
Company Filing History:
Years Active: 2017-2019
Title: Innovations of Israel Dvorsky in Neural Stimulation Technology
Introduction
Israel Dvorsky is a notable inventor based in Tel Aviv, Israel. He has made significant contributions to the field of neural stimulation technology, holding a total of three patents. His work focuses on developing advanced systems for delivering neural stimulators, which have important applications in medical treatments.
Latest Patents
Dvorsky's latest patents include an implant and delivery system for a neural stimulator. This apparatus is designed for the delivery of an implantable neural stimulator to the sphenopalatine ganglion (SPG) of a subject. The system features a tool with a proximal portion and a distal portion that is coupled to the implantable neural stimulator. A slide-bar at the proximal portion allows for the distal advancement of the stimulator through magnetic coupling elements. Another patent involves an optical fiber shape-sensing system, which includes an optical fiber that changes shape during advancement through the greater palatine canal. This system is designed to deliver a neural stimulator implant to the SPG without direct contact with the optical fiber.
Career Highlights
Israel Dvorsky is currently associated with Brainsgate Ltd., a company that specializes in innovative medical technologies. His work at Brainsgate has been pivotal in advancing the field of neural stimulation, particularly in developing systems that enhance the precision and effectiveness of treatments.
Collaborations
Dvorsky has collaborated with notable colleagues, including Avinoam Dayan and Hernan Altman. These collaborations have contributed to the successful development of his innovative technologies.
Conclusion
Israel Dvorsky's contributions to neural stimulation technology exemplify the impact of innovation in medical science. His patents reflect a commitment to improving patient care through advanced medical devices.